Bevacizumab versus ziv-aflibercept in branch retinal vein occlusion

Show simple item record

dc.contributor.author Braimah, I.Z.
dc.contributor.author Singh, S.R.
dc.contributor.author Uplanchiwar, B.
dc.contributor.author Mansour, A.M.
dc.contributor.author Chhablani, J.
dc.date.accessioned 2019-09-11T10:56:24Z
dc.date.available 2019-09-11T10:56:24Z
dc.date.issued 2019-07-07
dc.identifier.citation Braimah IZ, Singh SR, Uplanchiwar B, Mansour AM, Chhablani J. Bevacizumab versus ziv‑aflibercept in branch retinal vein occlusion. Indian J Ophthalmol 2019;67:1109-13. en_US
dc.identifier.other 10.4103/ijo.IJO_1532_18
dc.identifier.uri http://ugspace.ug.edu.gh/handle/123456789/32131
dc.description Research Article en_US
dc.description.abstract PURPOSE: To compare the effectiveness of treatment with intravitreal bevacizumab (IVB) and ziv-aflibercept (IVZ) in patients with macular edema (ME) post-branch retinal vein occlusion (BRVO). METHODS: Patients with treatment naïve ME post-BRVO were included retrospectively if they received either IVB (0.05 ml/1.25 mg) or IVZ (0.05 ml/1.25 mg) monotherapy with a follow up of 12 months. RESULTS: Thirty-two and 17 eyes received IVB and IVZ, respectively. The mean improvement in best corrected visual acuity (BCVA) was 0.36 ± 0.3 logarithm of minimum angle of resolution (logMAR) in the IVB group and 0.27 ± 0.3 in the IVZ group (P = 0.35). The mean change in central macular thickness was 178.9 ± 180.9 and 173.5 ± 344.4 μm in IVB and IVZ groups, respectively (P = 0.94). The mean number of injections was higher in the IVB group (4.0 ± 1.8) compared with 1.82 ± 0.8 in the IVZ group (P < 0.0001). The IVZ group had significantly fewer number of visits (P < 0.0001) and longer maximum treatment-free intervals (P = 0.0081). CONCLUSION: IVZ appears to be cost-effective with the similar visual outcome and less number of visits in comparison to IVB. en_US
dc.language.iso en en_US
dc.publisher Indian Journal of Ophthalmology en_US
dc.relation.ispartofseries 67;7
dc.subject Branch retinal venous occlusion en_US
dc.subject bevacizumab en_US
dc.subject Ziv‑aflibercept en_US
dc.subject macular edema en_US
dc.subject optical coherence tomography en_US
dc.title Bevacizumab versus ziv-aflibercept in branch retinal vein occlusion en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search UGSpace


Browse

My Account